Teixeira J - Search Results

1

Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.

Laurich VM, Trbovich AM, O'Neill FH, Houk CP, Sluss PM, Payne AH, Donahoe PK, Teixeira J. Laurich VM, et al. Among authors: teixeira j. Endocrinology. 2002 Sep;143(9):3351-60. doi: 10.1210/en.2001-211352. Endocrinology. 2002. PMID: 12193547

2

New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity.

Lorenzo HK, Teixeira J, Pahlavan N, Laurich VM, Donahoe PK, MacLaughlin DT. Lorenzo HK, et al. Among authors: teixeira j. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 5;766(1):89-98. doi: 10.1016/s0378-4347(01)00436-4. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 11820299

3

Regulation of gonadotropin gene expression by Mullerian inhibiting substance.

Bédécarrats GY, O'Neill FH, Norwitz ER, Kaiser UB, Teixeira J. Bédécarrats GY, et al. Among authors: teixeira j. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9348-53. doi: 10.1073/pnas.1633592100. Epub 2003 Jul 23. Proc Natl Acad Sci U S A. 2003. PMID: 12878721 Free PMC article.

4

Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens.

Houk CP, Pearson EJ, Martinelle N, Donahoe PK, Teixeira J. Houk CP, et al. Among authors: teixeira j. Endocrinology. 2004 Mar;145(3):1269-75. doi: 10.1210/en.2003-1046. Epub 2003 Nov 20. Endocrinology. 2004. PMID: 14630719

5

Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.

Donahoe PK, Clarke T, Teixeira J, Maheswaran S, MacLaughlin DT. Donahoe PK, et al. Among authors: teixeira j. Mol Cell Endocrinol. 2003 Dec 15;211(1-2):37-42. doi: 10.1016/j.mce.2003.09.009. Mol Cell Endocrinol. 2003. PMID: 14656474 Review.

6

Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.

Trbovich AM, Martinelle N, O'Neill FH, Pearson EJ, Donahoe PK, Sluss PM, Teixeira J. Trbovich AM, et al. Among authors: teixeira j. J Steroid Biochem Mol Biol. 2004 Oct;92(3):199-208. doi: 10.1016/j.jsbmb.2004.07.002. J Steroid Biochem Mol Biol. 2004. PMID: 15555913

7

Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.

Renlund N, O'Neill FH, Zhang L, Sidis Y, Teixeira J. Renlund N, et al. Among authors: teixeira j. J Endocrinol. 2007 Oct;195(1):95-103. doi: 10.1677/JOE-07-0281. J Endocrinol. 2007. PMID: 17911401

8

c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.

Renlund N, Pieretti-Vanmarcke R, O'Neill FH, Zhang L, Donahoe PK, Teixeira J. Renlund N, et al. Among authors: teixeira j. Endocrinology. 2008 Jan;149(1):108-15. doi: 10.1210/en.2007-0529. Epub 2007 Oct 18. Endocrinology. 2008. PMID: 17947357 Free PMC article.

9

Developmental expression of a candidate müllerian inhibiting substance type II receptor.

Teixeira J, He WW, Shah PC, Morikawa N, Lee MM, Catlin EA, Hudson PL, Wing J, Maclaughlin DT, Donahoe PK. Teixeira J, et al. Endocrinology. 1996 Jan;137(1):160-5. doi: 10.1210/endo.137.1.8536608. Endocrinology. 1996. PMID: 8536608

10

Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.

Catlin EA, Tonnu VC, Ebb RG, Pacheco BA, Manganaro TF, Ezzell RM, Donahoe PK, Teixeira J. Catlin EA, et al. Among authors: teixeira j. Endocrinology. 1997 Feb;138(2):790-6. doi: 10.1210/endo.138.2.4906. Endocrinology. 1997. PMID: 9003016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,871 results

Search Page